About Centene Corporation
https://www.centene.comCentene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States.
CEO
Sarah M. London
Compensation Summary
(Year 2005)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2019-02-07 | Forward | 2:1 |
| 2015-02-20 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 657
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Truist Securities
Buy
Bernstein
Outperform
Oppenheimer
Outperform
Wells Fargo
Equal Weight
Barclays
Equal Weight
Morgan Stanley
Equal Weight
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:56.79M
Value:$2.62B
BLACKROCK INC.
Shares:47.44M
Value:$2.19B
BLACKROCK, INC.
Shares:45.35M
Value:$2.09B
Summary
Showing Top 3 of 1,186
About Centene Corporation
https://www.centene.comCentene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $49.69B ▲ | $15.09B ▲ | $-6.63B ▼ | -13.34% ▼ | $-13.5 ▼ | $-6.19B ▼ |
| Q2-2025 | $48.74B ▲ | $3.4B ▼ | $-253M ▼ | -0.52% ▼ | $-0.51 ▼ | $228M ▼ |
| Q1-2025 | $46.62B ▲ | $3.67B ▲ | $1.31B ▲ | 2.81% ▲ | $2.64 ▲ | $2.23B ▲ |
| Q4-2024 | $40.8B ▼ | $3.54B ▲ | $283M ▼ | 0.69% ▼ | $0.57 ▼ | $833M ▼ |
| Q3-2024 | $42.02B | $3.37B | $713M | 1.7% | $1.37 | $1.41B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $19.24B ▲ | $82.09B ▼ | $61.03B ▲ | $20.95B ▼ |
| Q2-2025 | $17.28B ▼ | $86.39B ▼ | $58.89B ▼ | $27.41B ▼ |
| Q1-2025 | $17.29B ▲ | $87.04B ▲ | $59.02B ▲ | $27.92B ▲ |
| Q4-2024 | $16.68B ▼ | $82.44B ▲ | $55.94B ▲ | $26.41B ▼ |
| Q3-2024 | $17.57B | $82.35B | $54.94B | $27.31B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-6.63B ▼ | $1.36B ▼ | $1.22B ▲ | $9M ▲ | $2.54B ▲ | $1.15B ▼ |
| Q2-2025 | $-259M ▼ | $1.78B ▲ | $-899M ▼ | $-1.17B ▼ | $-302M ▼ | $1.58B ▲ |
| Q1-2025 | $1.31B ▲ | $1.51B ▲ | $-529M ▼ | $-250M ▼ | $752M ▲ | $1.38B ▲ |
| Q4-2024 | $275M ▼ | $-587M ▲ | $102M ▲ | $-13M ▲ | $-514M ▲ | $-741M ▲ |
| Q3-2024 | $710M | $-978M | $-839M | $-1.25B | $-3.03B | $-1.13B |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 Commercial Segment | $25.95Bn ▲ | $10.99Bn ▼ | $10.07Bn ▼ | $10.15Bn ▲ |
 Medicaid Segment | $92.98Bn ▲ | $37.35Bn ▼ | $37.45Bn ▲ | $35.19Bn ▼ |
 Other Operating Segment | $0 ▲ | $1.34Bn ▲ | $1.22Bn ▼ | $1.28Bn ▲ |
CEO
Sarah M. London
Compensation Summary
(Year 2005)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2019-02-07 | Forward | 2:1 |
| 2015-02-20 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 657
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Truist Securities
Buy
Bernstein
Outperform
Oppenheimer
Outperform
Wells Fargo
Equal Weight
Barclays
Equal Weight
Morgan Stanley
Equal Weight
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:56.79M
Value:$2.62B
BLACKROCK INC.
Shares:47.44M
Value:$2.19B
BLACKROCK, INC.
Shares:45.35M
Value:$2.09B
Summary
Showing Top 3 of 1,186